Eline Dejonckheere

Development and validation of a small single-domain antibody that effectively inhibits matrix metalloproteinase 8

Delphine Demeestere (UGent) , Eline Dejonckheere (UGent) , Sophie Steeland (UGent) , Paco Hulpiau (UGent) , Jurgen Haustraete (UGent) , Nick Devoogdt, Rielana Wichert, Christoph Becker-Pauly, Elien Van Wonterghem (UGent) , Sylviane Dewaele (UGent) , et al.

(2016) MOLECULAR THERAPY. 24(5). p.890-902

Add to list

Journal Article
A1
open access

Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF

Roosmarijn Vandenbroucke (UGent) , Eline Dejonckheere (UGent) , Filip Van Hauwermeiren (UGent) , Sofie Lodens, Riet De Rycke (UGent) , Elien Van Wonterghem (UGent) , An Staes (UGent) , Kris Gevaert (UGent) , Carlos López-Otin and Claude Libert (UGent)

(2013) EMBO MOLECULAR MEDICINE. 5(7). p.1000-1016

Add to list

Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases

Roosmarijn Vandenbroucke (UGent) , Eline Dejonckheere (UGent) , Philippe Van Lint, Delphine Demeestere (UGent) , Elien Van Wonterghem (UGent) , Ineke Vanlaere (UGent) , Leen Puimège (UGent) , Filip Van Hauwermeiren (UGent) , Riet De Rycke (UGent) , Conor Mc Guire (UGent) , et al.

(2012) JOURNAL OF NEUROSCIENCE. 32(29). p.9805-9816

Add to list

PhD Thesis

The role of MMP8 in TLR4-mediated acute systemic inflammation

Eline Dejonckheere (UGent)

(2011)

Add to list

A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?

Roosmarijn Vandenbroucke (UGent) , Eline Dejonckheere (UGent) and Claude Libert (UGent)

(2011) EUROPEAN RESPIRATORY JOURNAL. 38(5). p.1200-1214

Add to list

Matrix metalloproteinases as drug targets in ischemia/reperfusion injury

Eline Dejonckheere (UGent) , Roosmarijn Vandenbroucke (UGent) and Claude Libert (UGent)

(2011) DRUG DISCOVERY TODAY. 16(17-18). p.762-778

Add to list

Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression

Eline Dejonckheere (UGent) , Roosmarijn Vandenbroucke (UGent) and Claude Libert (UGent)

(2011) CYTOKINE & GROWTH FACTOR REVIEWS. 22(2). p.73-81

Add to list

Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?

Lien Dejager (UGent) , Iris Pinheiro, Eline Dejonckheere (UGent) and Claude Libert (UGent)

(2011) TRENDS IN MICROBIOLOGY. 19(4). p.198-208

Add to list

Type I interferon drives tumor necrosis factor-induced lethal shock

Liesbeth Huys (UGent) , Filip Van Hauwermeiren (UGent) , Lien Dejager (UGent) , Eline Dejonckheere (UGent) , Stefan Lienenklaus, Siegfried Weiss, Georges Leclercq (UGent) and Claude Libert (UGent)

(2009) JOURNAL OF EXPERIMENTAL MEDICINE. 206(9). p.1873-1882

Academic Bibliography

Eline Dejonckheere

Development and validation of a small single-domain antibody that effectively inhibits matrix metalloproteinase 8

Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF

Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases

The role of MMP8 in TLR4-mediated acute systemic inflammation

A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?

Matrix metalloproteinases as drug targets in ischemia/reperfusion injury

Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression

Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?

Type I interferon drives tumor necrosis factor-induced lethal shock

Contents

Support

Contact